Abstract: The present application relates to a use of a strain of the genus Cutibacterium, a culture of the strain, or a combination thereof for prevention, amelioration, and/or treatment of inflammatory skin diseases. A composition comprising a strain of the genus Cutibacterium, a culture of the strain, or a combination thereof does not show cytotoxicity, inhibits proliferation of immune cells that cause skin inflammation, suppresses immune responses, has an antibacterial effect against acne-causing bacteria, and promotes regeneration of skin cells, thereby exhibiting excellent preventive, ameliorating, and/or therapeutic effects of inflammatory skin diseases.

Abstract: A seat adjustment apparatus for a vehicle includes a plurality of connection frames provided along two opposite sides of a seat frame and two opposite sides of a back frame and configured to move forward or rearward depending on a folding direction of the back frame, guide parts provided at middle points of the plurality of connection frames and configured to be moved upward or downward by forward or rearward movements of the connection frames, and a seat cushion pipe provided inside the two connection frames and configured such that front ends of the seat cushion pipe are connected to the guide parts, and a position of a rear end of the seat cushion pipe is adjusted upward or downward by upward or downward movements of the guide parts.

Abstract: The present disclosure relates to a novel Leuconostoc mesenteroides strain.

Abstract: The present disclosure relates to compositions containing a novel Leuconostoc mesenteroides strain, a culture thereof, or a component derived therefrom for preventing, alleviating, or treating cancer or inflammation.

Abstract: A pixel circuit includes a sensing block, a stimulation block, a first line control circuit, and a second line control circuit. The sensing block outputs biometric data of a biosignal in response to a first selection signal. The stimulation block radiates a stimulation signal in response to a second selection signal. The first line control circuit outputs the first selection signal for selecting the sensing block as a target sensing block, and outputs the second selection signal for selecting the stimulation block as a target stimulation block. The second line control circuit processes characteristic data associated with the biometric data and the stimulation signal.

Abstract: The present invention relates to a composition which is for preventing and ameliorating or treating premenstrual syndrome symptoms, and includes: (a) a Chrysanthemum zawadskii extract; (b) a mixture of the Chrysanthemum zawadskii extract and a malt extract; or (c) a mixture of the Chrysanthemum zawadskii extract, the malt extract, and an aloe extract. Specifically, the present compositions effectively inhibit the secretion of prolactin from pituitary cells, which is a phenomenon that appears during premenstrual syndrome, thereby increasing the secretion of progesterone, which is reduced during the luteal phase of women, and can thus be advantageously used as a composition for preventing and ameliorating or treating women's premenstrual syndrome.

Abstract: Provided is a bio-signal detection and stimulation device. The bio-signal detection and stimulation device includes a flexible substrate, a stimulation part on the flexible substrate, and a detection electrode part on the flexible substrate. The stimulation part and the detection electrode part vertically overlap each other, the stimulation part includes an organic light emitting diode (OLED), the stimulation part emits an optical signal, and the detection electrode part detects a bio-signal.

Abstract: An embodiment luggage gap cover device for a rear seat of a vehicle is provided. The rear seat includes an interlocking frame connecting a seatback of the rear seat to a seat cushion for a dive operation, and the luggage gap cover device includes a foldable cover mat on a rear surface of the seatback configured to cover a gap between the seatback and a floor plate of a luggage compartment and a support protrusion on the interlocking frame, the support protrusion being configured to push and support the cover mat in a direction of covering the gap between the seatback and the floor plate.

Abstract: A semiconductor device may include: a first conductive line extending in a first direction; a second conductive line disposed over the first conductive line to be spaced apart from the first conductive line and extending in a second direction different from the first direction; and a selector layer disposed between the first conductive line and the second conductive line and extending in a direction crossing at least one of the first direction or the second direction, wherein the selector layer includes a trench formed on a surface of the selector layer and extending in the direction crossing at least one of the first direction or the second direction.

Abstract: The present invention relates to a composition for controlling anti-obesity activity, containing, as an active ingredient, a Moringa oleifera fermentation product prepared using a novel Monascus purpureus SL1 strain, wherein the Moringa oleifera fermentation product provided in the present invention remarkably inhibits the differentiation of adipocytes and the Moringa oleifera fermentation product of the present invention has anti-obesity effects that are remarkably superior to those of Moringa oleifera powder.

Abstract: An ADAMTS13 mutant protein having an improved escaping rate against an autoantibody and a composition that is suitable for preventing or treating thrombotic diseases are disclosed. By efficiently avoiding autoantibodies known to have high binding affinity to the main domain of ADAMTS13, the ADAMTS13 variant protein of the present invention can be used as an effective therapeutic composition for various thrombotic diseases, such as TTP (thrombotic thrombocytopenic purpura), in which the presence of such autoantibodies is the main etiology, and can stably maintain the biological activity thereof when administered into a body. In addition, a newly identified site within ADAMTS13, which is recognized by an autoantibody can be used in screening novel ADAMTS13 variants having an improved autoantibody escaping rate by applying a combination of various mutations within the corresponding site.

Abstract: The present invention relates to a composition comprising a Salvia miltiorrhiza extract for prevention and treatment of depression in menopausal women. The Salvia miltiorrhiza extract of the present invention is characterized by regulating the release of luteinizing hormone and follicle-stimulating hormone and increasing the release of serotonin and norepinephrine to prevent, alleviate, and treat the hormonal change and depression occurring after menopause. In addition, since the raw material is highly stable, the composition comprising a danshensu-containing Salvia miltiorrhiza extract as an active ingredient retains the efficacy during long-term storage and thus can be suitable for use as an industrial substance.

Abstract: Provided is a lactic acid bacteria composition that is stable under strong acid conditions caused by gastric acid, bile acid, or the like, and specifically, to a lactic acid bacteria composition containing a Lactobacillus paracasei strain and an amino acid as active ingredients. The lactic acid bacteria composition according to the present invention may survive even under strong acidic conditions caused by gastric acid or bile acid and reach the intestine alive, and thus defend against and attack harmful bacteria in the intestine, multiply, produce metabolites, and promote metabolite production, thereby activating the immune system.

Abstract: A vehicle speed controlling apparatus comprising a driving mode selector configured to receive a selection of a periodic-speed driving mode from a user, a driving strategy control unit including a speed profile generator configured to generate a periodic-speed driving speed profile with a period, an amplitude, and an average speed, and a driving assistance unit configured to output a required torque for a driving motor to follow the periodic-speed driving speed profile.

Abstract: A vehicle running mode control method may include detecting, by a mode controller, a mode switching from an electric vehicle mode (EV mode) to a hybrid electric vehicle mode (HEV mode) while a vehicle runs; and performing a continuously variable transmission (CVT) cooperative mode switching control in which a drive motor is connected to an engine by engaging a clutch by operating the CVT.

Abstract: In a cruise control method and a cruise control apparatus for a manual transmission vehicle, upon receiving a signal from an input device to start a cruise mode, a cruise control controller calculates an optimal gear stage for satisfying a target cruise traveling speed according to a traveling state of a vehicle, and a display device displays the calculated optimal gear stage to the driver to induce the driver to shift to the optimal gear stage. In addition, whether the gear stage by the driver's operation has matched the optimal gear stage may be determined within a predetermined time to determine whether a cruise control continues according to the determination result, thereby eliminating the driver's inconvenience due to frequent cancellation of the cruise mode.

Abstract: A system for preventing abnormal acceleration of a vehicle includes a device configured such that in a state in which the vehicle is stopped while the vehicle is turned on, the device is configured to determine whether abnormal acceleration prevention is necessary based on a final destination or a current position of the vehicle before the vehicle is turned off to thereby limit a vehicle speed. The system and a method for preventing abnormal operation of the vehicle can prevent a vehicle accident due to the abnormal acceleration caused by misoperation by a driver, such as misoperation of an accelerator pedal of the vehicle.

Abstract: A system for controlling a remote smart parking assist (RSPA) system is provided. The system includes an engine control unit (ECU) that is configured to operate an engine and an RSPA controller that is configured to receive vehicle state information from the ECU regarding whether or not a vehicle system error occurs and, if an error occurs, whether or not the error is an error in which a vehicle is possible to be driven. The RSPA controller is further configured to transmit torque request information to the ECU when the vehicle system error is an error in which the vehicle is possible to be driven.

Abstract: The present invention relates to a composition which is for preventing and ameliorating or treating premenstrual syndrome symptoms, and includes: (a) a Chrysanthemum zawadskii extract; (b) a mixture of the Chrysanthemum zawadskii extract and a malt extract; or (c) a mixture of the Chrysanthemum zawadskii extract, the malt extract, and an aloe extract. Specifically, the present compositions effectively inhibit the secretion of prolactin from pituitary cells, which is a phenomenon that appears during premenstrual syndrome, thereby increasing the secretion of progesterone, which is reduced during the luteal phase of women, and can thus be advantageously used as a composition for preventing and ameliorating or treating women's premenstrual syndrome.

Abstract: Provided is an inhibitor of an indoleamine 2,3-dioxygenase (IDO) and/or tryptophan 2,3-dioxygenase (TDO) of formula (I) or a pharmaceutically acceptable salt thereof: in which W1, W2, W3, and W4, X, Y, Z1, Z2, and R1-7 are described herein. Further provided is a method of treating or preventing a IDO and/or TDO-mediated disease using an effective amount of the compound of formula (I) or a pharmaceutically acceptable salt thereof.